KLHL14, or Kelch-like protein 14, is a member of the Kelch-like (KLHL) family of proteins and is encoded by the KLHL14 gene in humans. This protein family is characterized by the presence of a Kelch repeat domain, which typically consists of a series of five to seven Kelch motifs that form a β-propeller tertiary structure. This structure is known to mediate protein-protein interactions and is involved in diverse cellular functions.The KLHL14 protein, like its family members, is also predicted to have a BTB/POZ domain in addition to the Kelch domain. The BTB/POZ domain is involved in protein dimerization and interaction with the Cullin 3 (Cul3) class of ubiquitin ligases, suggesting that KLHL14 might play a role in the ubiquitination pathway-a critical mechanism for protein degradation and regulation within the cell.
While the exact physiological functions of KLHL14 remain to be fully elucidated, proteins in the KLHL family are generally implicated in a variety of biological processes, including cytoskeletal organization, cell morphology, and the regulation of signal transduction pathways. Given its structural features, KLHL14 may be involved in similar processes, potentially serving as an adaptor that brings specific substrate proteins to the Cul3 ubiquitination complex, thereby targeting them for degradation.Studies of KLHL14 often focus on tissue-specific expression, the identification of its substrate proteins, and its role in ubiquitin-mediated proteolysis. Insights into these areas could reveal the underlying mechanisms by which KLHL14 influences cellular processes and contributes to the maintenance of cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, potentially affecting ubiquitin-mediated protein degradation pathways involving KLHL14. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, might impact protein degradation pathways relevant to KLHL14. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor, could influence KLHL14-related processes. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates the ubiquitin-proteasome system, potentially affecting KLHL14's role in protein ubiquitination. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Influences multiple signaling pathways, potentially impacting KLHL14. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, might influence cellular processes relevant to KLHL14's function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling, potentially intersecting with pathways involving KLHL14. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, can impact gene expression and potentially KLHL14 function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Alters DNA methylation, potentially impacting gene expression patterns relevant to KLHL14. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Influences histone acetylation, potentially affecting the expression of genes like KLHL14. | ||||||